EP Patent

EP0109023A1 — Isoquinolinesulfonamide derivatives and process for the preparation thereof

Assigned to Asahi Kasei Corp · Expires 1984-05-23 · 42y expired

What this patent protects

This invention relates to novel isoquinolinesulfonamide derivatives of Formula (I): <IMAGE> (I) wherein A is a C0-10 alkylene group or a C0-10 alkylene group having a C1-10 alkyl group, a phenyl group, a substituted phenyl group or a phenylalkyl group; R1 and R2 each is …

USPTO Abstract

This invention relates to novel isoquinolinesulfonamide derivatives of Formula (I): <IMAGE> (I) wherein A is a C0-10 alkylene group or a C0-10 alkylene group having a C1-10 alkyl group, a phenyl group, a substituted phenyl group or a phenylalkyl group; R1 and R2 each is a hydrogen atom; or R1 and R2 are linked directly to form an ethylene group unsubstituted or substituted with a C1-4 alkyl group; R3 and R4 each is a hydrogen atom, a C1-6 alkyl group or linked directly to form a C2-6 alkylene group; and the pharmaceutically acceptable acid addition salt thereof, and to a process for preparing them. The isoquinoline derivatives possess a relaxatory action for vascular smooth muscle and action for increasing blood flow and are useful as a vasodilator and a hypotensor.

Drugs covered by this patent

Patent Metadata

Patent number
EP0109023A1
Jurisdiction
EP
Classification
Expires
1984-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Asahi Kasei Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.